Format

Send to

Choose Destination
Leukemia. 2016 Jun;30(6):1413-5. doi: 10.1038/leu.2015.310. Epub 2015 Nov 3.

Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis.

Author information

1
Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
2
Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
3
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
4
Incyte Corporation, Wilmington, DE, USA.
5
Department of Medicine, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
6
Division of Hematology & Medical Oncology, Mayo Clinic Cancer Center, Scottsdale, AZ, USA.
7
Department of Medicine/Division of Hematology, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA.
PMID:
26526986
PMCID:
PMC4895165
DOI:
10.1038/leu.2015.310
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center